14. Will Inhibitors of GTωA Enzymes, Perhaps in Combination with Inhibitors of GLS1, Glutamine Transporters, or Other Proteins/Enzymes, Be Clinically Useful in Cancer Patients? The gene discussed is GLS; the disease is cancer.